文献速递围术期管理与 ERAS胃肠外科

严重肥胖肾移植受者术前减重手术的长期随访结局

Outcomes of kidney transplant recipients who underwent pre-transplant bariatric surgery for severe obesity: a long-term follow-up study.
PubMed 文献 · Surg Endosc · 2022-08-24

单中心回顾性随访研究纳入32例晚期慢性肾病或终末期肾病(ESRD)患者,2013至2018年因争取肾移植(KT)资格接受袖状胃切除术(SG)。末次随访时23例(72%)成功接受KT,移植后中位随访16个月仅1例移植物丢失需恢复透析,移植后5年中位血肌酐136 µmol/l,体重与肥胖相关合并症持续改善。

要点

  • SG可提高严重肥胖ESRD患者接受肾移植的可及性,本队列72%最终接受KT。
  • 移植后体重维持下降,糖尿病与高血压部分改善或缓解。
  • 移植后中位随访16个月仅1例移植物丢失,5年中位血肌酐136 µmol/l。

核心结论

  • SG是改善严重肥胖患者接受肾移植可及性的有效策略。
  • 移植受者持续受益于体重下降和合并症改善,可能对移植后移植物功能产生积极影响。

研究设计与样本

  • 单中心回顾性随访研究,纳入32例晚期慢性肾病或ESRD并接受SG作为肾移植准入策略的患者。
  • SG实施时间为2013至2018年,主要结局为成功接受肾移植。

主要发现

  • 基线时18例(56%)为男性,中位年龄51(11)岁,中位BMI 42.3(5.2)kg/m2。
  • SG后中位随访53(58)个月,末次随访时23例(72%)接受KT,中位等待KT时间16(20)个月。
  • 移植时中位BMI 34.0(5.1)kg/m2,13例(57%)有糖尿病,20例(87%)有高血压。
  • 移植后中位随访16(47)个月,1例移植物丢失需恢复透析;移植后5年中位血肌酐136(66)µmol/l。
  • 末次随访中位BMI 33.7(7.6)kg/m2;糖尿病患者7/13(54%)、高血压患者5/20(25%)合并症改善或缓解。

临床怎么用

  • 对严重肥胖且因体重受阻于肾移植资格的晚期CKD或ESRD患者,可考虑SG作为准入策略。
  • 移植后应继续监测体重、血肌酐及糖尿病和高血压等合并症变化。

局限性

  • 单中心回顾性设计,样本量32例,结果外推需谨慎。
  • 移植后随访时间中位16个月、离散度大,长期移植物结局证据仍有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kidney transplantation (KT) is the preferred therapy for end-stage renal disease (ESRD). While a major cause for ESRD, obesity is also a key obstacle to candidacy for KT. Bariatric surgery, particularly sleeve gastrectomy (SG), is increasingly used to improve access to KT in patients with obesity, but the literature especially on outcomes post-KT remains lacking. We aimed to provide a long-term follow-up analysis of efficacy and outcomes of a previously described cohort of patients with obesity, who had SG as a means for access to KT. METHODS: This is a single-center retrospective follow-up study of 32 patients with advanced chronic kidney disease or ESRD, who were referred and underwent SG between 2013 and 2018 as an access strategy to KT. The primary outcome was successful KT. Ninety-day outcomes, long-term graft function, and changes in weight and obesity-related comorbidities after KT were assessed. Descriptive statistics are presented as count (percentage) or median (interquartile range). RESULTS: At baseline, 18 (56%) were male with a median age and BMI of 51 (11) years and 42.3 (5.2) kg/m2, respectively. Median follow-up time post-SG was 53 (58) months. At last follow-up, 23 (72%) patients received KT. Median time to KT was 16 (20) months and BMI was 34.0 (5.1) kg/m2 at time of transplant. At KT, 13 (57%) and 20 (87%) had diabetes and hypertension, respectively. Median follow-up post-KT was 16 (47) months. There was one graft loss requiring return to dialysis. At 5-year post-KT, median serum creatinine was 136 (66) µmol/l. At last follow-up post-KT, median BMI remained at 33.7 (7.6) kg/m2. Among patients with diabetes and hypertension, 7/13 (54%) and 5/20 (25%) had either improvement or remission of their comorbidities, respectively. CONCLUSION: SG is an effective strategy to improve access to KT in patients with severe obesity. Transplant recipients also continue to benefit from sustained weight loss and improved related comorbidities that may positively impact their graft function after KT.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zaminpeyma R, Claus M, Paraskevas S, et al. Outcomes of kidney transplant recipients who underwent pre-transplant bariatric surgery for severe obesity: a long-term follow-up study. Surg Endosc. 2022. PMID: 36002684. doi:10.1007/s00464-022-09552-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。